Flow Cytometer, Flow Cytometry

Flow Cytometer, Flow Cytometry

Research, Development
Flow Cytometer, Flow Cytometry
Flow Cytometer, Flow Cytometry

Information

BIOSINO (Suzhou) Medical Technology Inc (referred to as: BIOSINO (Suzhou)) was founded on May 22, 2009, is a holding subsidiary of BioSino Bio-Technology and Science Inc. (referred as BIOSINO). Biosino (Suzhou) Medical Technology Inc. Located in Jiangsu Medical Device Science and Technology Industrial Park, it is a holding subsidiary of Biosino Bio-Technology and Science Inc. (08247 · HK) under the Chinese Academy of Sciences. A core R&D team with PHDs and masters as the main body has been formed, and more than 90% of them are undergraduates. Ø A high-tech biotechnology company dedicated to the R&D, production and sales of in vitro diagnostic equipment and reagents. Biosino (Hefei) Medical Technology Inc. was founded on April 22, 2022, The production base has signed a contract to settle in the second phase of the Intelligent Science and Technology Park in Hefei Economic and Technological Development Zone, a 3,000 square meter production site for flow cytometry instruments and reagents. Ø The R&D Center signed a contract to settle in the Institute of Great Health of Hefei Comprehensive National Science Center.
BioSino Bio-Technology And Science Inc.H3.B59BioSino Bio-Technology and Science Inc. is a high-tech listed enterprise founded and controlled by the Institute of Biophysics, Chinese Academy of Sciences. It is mainly engaged in the research and development, production, sales and service of in vitro diagnostic products. Since its establishment in 1973, it has always been oriented to meet people's livelihood needs, actively promote the development of the national IVD industry, create an independent innovation system that combines production, academia, research and application, and explore "international, group-based, and complex" operations model. Build a full industrial chain integrating "systematization, serialization, integration and intelligence" to enhance core competitiveness and establish a leading position in the industry. Since the company pioneered China's enzymatic single and double biochemical reagents, after years of development, it has established a complete biochemical detection series product platform and developed a series of in vitro diagnostic products such as immunology, molecules, and flow cytometry. The company has a R&D team composed of several doctors and masters, established a "corporate postdoctoral research workstation", established an in vitro diagnostic engineering research center jointly with the highest-level scientific research institutions in the field of domestic life sciences, and carried out comprehensive cooperation with internationally renowned companies. The company has repeatedly undertaken a series of national science and technology tasks such as the national "863 Plan", the National Science and Technology Support Plan, the National High-tech Industry Demonstration Project, and the Chinese Academy of Sciences Knowledge Innovation Project, and has been recognized as an "innovative enterprise" in the National Independent Innovation Demonstration Zone. The company has a production base of 16000 square meters built strictly in accordance with GMP standards. It has passed quality management system certifications such as ISO9001, ISO13485, CE, KGMP, and CMDCAS. It has also been recognized by ISO/ICE17025:2005 "General Requirements for the Competence of Inspection and Calibration Laboratories" and has obtained the use of the CNAS laboratory accreditation mark. At present, it has obtained more than 260 in vitro diagnostic reagent product registration certificates, mainly covering 12 types of biochemical testing items such as liver function, kidney function, blood lipid, cardiovascular, diabetes, rheumatism, etc., and is one of the most complete manufacturers of biochemical diagnostic reagent products in China. The company has more than 500 agents and sellers, has established branches in most provinces across the country and overseas, and has established a nationwide marketing network and technical service support system. Over the years, the company's biochemical diagnostic products have been at the forefront of the domestic market and have continued to expand overseas markets. The products are exported to more than 60 countries and regions in Europe, North America, Africa and Southeast Asia. Looking forward to the future, Biosino will continue to launch more, newer and better products and services as always, and is committed to making greater contributions to the development of in vitro diagnostic industry and the health of the people!

Log in

See all the content and easy-to-use features by logging in or registering!